These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5036506)

  • 21. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 22. Levodopa in Parkinsonism.
    Weiss JL; Chase TN
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE
    JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract]   [Full Text] [Related]  

  • 24. L-Dopa in the treatment of parkinsonism.
    Calne DB
    Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
    Schneider E; Fischer PA; Jacobi P; Maxion H
    Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
    [No Abstract]   [Full Text] [Related]  

  • 26. L-dopa. II.
    Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.
    Fazio C; Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Volante F
    Z Neurol; 1972; 202(4):347-55. PubMed ID: 4117654
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.
    Rinne UK; Sonninen V; Sirtola T
    Z Neurol; 1972; 202(1):1-20. PubMed ID: 4114458
    [No Abstract]   [Full Text] [Related]  

  • 29. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1971; 3(3):121-30. PubMed ID: 5156174
    [No Abstract]   [Full Text] [Related]  

  • 33. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
    Kuran W
    Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001
    [No Abstract]   [Full Text] [Related]  

  • 34. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 36. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J; Holmsen R
    Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract]   [Full Text] [Related]  

  • 38. The patient's view of L-Dopa after one year's therapy.
    Hildick-Smith M
    Gerontol Clin (Basel); 1973; 15(2):74-83. PubMed ID: 4753782
    [No Abstract]   [Full Text] [Related]  

  • 39. An evaluation of L-dopa in Parkinson patients.
    Mones RJ
    Trans Am Neurol Assoc; 1969; 94():307-9. PubMed ID: 5374472
    [No Abstract]   [Full Text] [Related]  

  • 40. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.